- Home
- CAC vs DNA Comparison
CAC vs DNA Comparison
Compare CAC & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- DNA
- Stock Information
- Founded
- CAC 1875
- DNA 2008
- Country
- CAC United States
- DNA United States
- Employees
- CAC N/A
- DNA N/A
- Industry
- CAC Major Banks
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAC Finance
- DNA Health Care
- Exchange
- CAC Nasdaq
- DNA Nasdaq
- Market Cap
- CAC 677.7M
- DNA 542.6M
- IPO Year
- CAC 1997
- DNA N/A
- Fundamental
- Price
- CAC $44.92
- DNA $9.50
- Analyst Decision
- CAC Hold
- DNA Hold
- Analyst Count
- CAC 2
- DNA 6
- Target Price
- CAC $45.00
- DNA $37.80
- AVG Volume (30 Days)
- CAC 53.5K
- DNA 1.3M
- Earning Date
- CAC 01-28-2025
- DNA 11-12-2024
- Dividend Yield
- CAC 3.75%
- DNA N/A
- EPS Growth
- CAC N/A
- DNA N/A
- EPS
- CAC 3.20
- DNA N/A
- Revenue
- CAC $168,756,000.00
- DNA $217,951,000.00
- Revenue This Year
- CAC N/A
- DNA N/A
- Revenue Next Year
- CAC $28.37
- DNA N/A
- P/E Ratio
- CAC $13.99
- DNA N/A
- Revenue Growth
- CAC N/A
- DNA N/A
- 52 Week Low
- CAC $28.62
- DNA $5.26
- 52 Week High
- CAC $50.07
- DNA $75.20
- Technical
- Relative Strength Index (RSI)
- CAC 45.57
- DNA 51.43
- Support Level
- CAC $44.79
- DNA $9.01
- Resistance Level
- CAC $46.17
- DNA $11.68
- Average True Range (ATR)
- CAC 1.05
- DNA 1.00
- MACD
- CAC -0.37
- DNA -0.08
- Stochastic Oscillator
- CAC 15.36
- DNA 30.87
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.